Contaminants in heparins: are all facts known?
Fareed
Jawed
J
Hoppensteadt
Debra A
DA
Ramacciotti
Eduardo
E
Hull
Russell D
RD
D000707:Anaphylaxis / Q000097:blood / Q000139:chemically induced; D000925:Anticoagulants / Q000032:analysis* / Q000302:isolation & purification / Q000627:therapeutic use; D002809:Chondroitin Sulfates / Q000009:adverse effects / Q000032:analysis* / Q000494:pharmacology; D004196:Disease Outbreaks; D004340:Drug Contamination; D004789:Enzyme Activation / Q000187:drug effects; D006493:Heparin / Q000032:analysis* / Q000302:isolation & purification / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007610:Kallikreins / Q000502:physiology; D015539:Platelet Activation / Q000187:drug effects; D011288:Prekallikrein / Q000187:drug effects / Q000378:metabolism; D011516:Prothrombin / Q000378:metabolism; D013917:Thrombin / Q000096:biosynthesis; D013921:Thrombocytopenia / Q000139:chemically induced
D000925:Anticoagulants; D011516:Prothrombin; D006493:Heparin; D002809:Chondroitin Sulfates; D011288:Prekallikrein; D007610:Kallikreins; D013917:Thrombin